Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, ...
Glaxosmithkline Pharmaceuticals Ltd share ... DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt.
AL002 misses Phase 2 goal in early Alzheimer's. Key Phase 3 data for latozinemab in 2025. Click here to read why ALEC is a ...
Annual ResultsBIOVERSYS ANNOUNCES REPORTING DATE FOR FULL-YEAR 2024 FINANCIAL RESULTS AND EVENT DETAILS 14.03.2025 / 07:00 CET/CESTBasel, Switzerland. March 14, 2025, 7am CETBioVersys AG (SIX: BIOV), ...
Hydration Boosters Market. The global hydration boosters market is poised for substantial growth, with a projected valuation ...
Getting a headache and feeling sick are common side-effects for many medicines. Indulging in risky sexual behaviour or pathological gambling - not so ...
All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.
Pursuant to Articles 10-14 of the Articles of Association, the shareholders of Bavarian Nordic A/S are hereby convened to the Annual General Meeting to be held on Wednesday, 9 April 2025, at 4 PM CEST ...
In 1950, the company synthesised the central nervous system treatment, chlorpromazine, which it later sold to GlaxoSmithKline ... company launched a dedicated website called Sanofi-Aventis TV ...
The global nicotine gums and mints market is projected to reach approximately USD 1,536.2 million by the end of 2024, with a ...
Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.
DUBLIN--(BUSINESS WIRE)--The "Enterprise Tech Ecosystem Series: GSK plc 2024" company profile has been added to ResearchAndMarkets.com's offering. The report provides insights into company's tech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results